Plain-English translation of NCT03199066 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term observational study that tracks patients diagnosed with non-Hodgkin lymphoma in the Czech Republic. Rather than testing a new drug or treatment, the study gathers detailed information about your diagnosis, the treatments you receive, and how you respond over time. This information helps doctors understand the disease patterns and outcomes across the country, so they can improve care for future patients.
Non-Hodgkin lymphoma is a complex disease with many different subtypes, each requiring different approaches. By collecting detailed information from thousands of patients over many years, doctors can identify patterns that help them choose the best treatments and predict outcomes more accurately.
You likely qualify if…
You likely don't qualify if…
When you enroll, your doctor will enter your lymphoma diagnosis information into a secure database. Your health information will be updated when you finish your first treatment, whenever you have a relapse, and then annually during follow-up visits. All your information is kept confidential. This continues for as long as you are being treated for lymphoma or until the end of the study.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
Czechia
Enrollment target
~20,000 participants
Started
January 1999
Primary completion
December 2020
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2017.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Marek Trneny, prof. MD
Charles University General Hospital, Prague, CZ
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.